Isochol (Hymecromone)

Hymecromone enhances bile secretion by increasing hepatocellular synthesis of bile acids and activating transport mechanisms that move bile into the gastrointestinal tract. It also reduces hyaluronan synthesis, which can lower bile viscosity and improve drainage.

The dosage of Isochol is determined by the prescribing healthcare professional based on the patient’s specific condition, severity, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Hymecromone in pregnancy and lactation are limited. Isochol should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To request Isochol, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Isochol’s active ingredient, Hymecromone, uniquely combines bile‑stimulating activity with inhibition of hyaluronan synthesis, which may offer advantages in reducing bile viscosity compared with some other choleretics that solely increase bile acid secretion.

Isochol should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Isochol is taken orally, usually with a glass of water. The exact timing relative to meals should follow the prescribing clinician’s guidance, as food may influence absorption for some patients.

Serious risks include significant elevation of liver enzymes indicating hepatic injury, severe allergic reactions such as rash or swelling, and persistent abdominal pain. Patients experiencing these symptoms should seek immediate medical attention.

Isochol is contraindicated in patients with known hypersensitivity to Hymecromone or any excipients in the formulation, and it should be used with caution in individuals with severe liver impairment or active hepatic disease unless specifically directed by a physician.